Focal Segmental Glomerulosclerosis (FSGS) Recruiting Phase 1 / 2 Trials for Metformin (DB00331)

Also known as: Focal Glomerulosclerosis / Glomerulosclerosis, Focal / Focal Segmental Glomerulosclerosis / Glomerulosclerosis, Focal Segmental / APOL1-mediated focal segmental glomerulosclerosis / Focal & segmental glomerulosclerosis / Focal glomerular sclerosis (disorder) / Focal segmental glomerulosclerosis (disorder)

IndicationStatusPhase
DBCOND0038485 (Focal Segmental Glomerulosclerosis (FSGS))Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06090227AMPK-activation by Metformin in FSGS: AMP-FSGSTreatment